Tuesday, October 4, 2022

561.316.3330

Biotechnology News Magazine

INTEGRA Solutions Are Helping to Support a New Generation of RNA Sequencing

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

INTEGRA Biosciences’ electronic handheld pipetting solutions are helping to improve the throughput capacity of bulk RNA barcoding and sequencing (BRB-seq) at Alithea Genomics in Switzerland.

The company’s fast, high throughput, and robust in-house BRB-seq service provides crucial gene expression data at a fraction of the cost and time of traditional RNA sequencing, and the company’s workflow relies on INTEGRA VIAFLO 96 and VIAFLO 384 electronic handheld pipettes to provide the speed and precision needed for seamless plate-to-plate transfers.

Traditional RNA sequencing protocols process samples individually, which can become extremely time-consuming and tiresome. That’s why Alithea Genomics offers a BRB-seq service that pools and processes samples together in a single tube, saving on both reagents and time, making this approach ideal for large-scale projects.

To offer customers enhanced speed, precision, and throughput, the company began using VIAFLO 96 and VIAFLO 384 pipetting systems for plate-to-plate transfers for its in-house service, as well as to assemble and aliquot sequencing kit plates to ship to customers.

Riccardo Dainese, CEO of Alithea, explained: “For us, the VIAFLO 96 and VIAFLO 384 provide the best balance between automation, pricing, and throughput. They allow us to seamlessly transfer and quickly process thousands of samples, while still retaining the flexibility to change between 96 to 384 channel pipetting heads as often as required.”

“Being able to guarantee the precision of plate-to-plate transfers has been so important – especially when preparing ready-to-use plates for our customers – because it translates directly into data accuracy and uniformity. The VIAFLO 96 and VIAFLO 384 can aspirate a defined volume, then simultaneously dispense multiple smaller aliquots into 96 or 384 well plates, providing us with a much more convenient workflow than manual pipetting, while helping to guarantee precision. The systems give us everything we need to achieve our target throughput, without the hefty price tag of a large, automated liquid handling robot,” Riccardo concluded.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine